Back to companies

Anixa Biosciences Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Anixa Biosciences Inc (Anixa) is a clinical-stage biotechnology company. It focuses on developing therapies and vaccines for the treatment and prevention of cancer. The company carries out the business of developing liraltagene autoleucel (lira-cel), a chimeric endocrine receptor-T cell therapy, which is a novel form of chimeric antigen receptor-T cell (CAR-T) technology for treating ovarian cancer and other solid tumors. It offers vaccines such as breast cancer vaccine, lung, colon and prostate cancer vaccines and ovarian cancer vaccines. The company partnerships with research institutions and healthcare organizations. Anixa is headquartered in San Jose, California, the US.

 Gain a 360-degree view of Anixa Biosciences Inc and make more informed decisions for your business Gain a 360-degree view of Anixa Biosciences Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address Suite 250, 3150 Almaden Expressway, San Jose, California, 95118
Website www.anixa.com
Telephone 1 408 7089808
No of Employees 4
Industry Medical Equipment
Ticker Symbol & Exchange ANIX (NASD)
EPS XYZ
Net Income (2024) XYZ 13% (2024 vs 2023)
Market Cap* $100.6M
Net Profit Margin (2022) XYZ 0.0% (2024 vs 2023)
   
* As of and is in US$
View Anixa Biosciences Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Anixa Biosciences Inc premium industry data and analytics

20+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

8

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

Products and Services

Products
Vaccines:
Breast Cancer Vaccine
Breast Cancer Vaccine
XYZ
XYZ
XYZ
Understand Anixa Biosciences Inc portfolio and identify potential areas for collaboration Understand Anixa Biosciences Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Anixa Biosciences Inc Legend Biotech Corp Arvinas Inc Tango Therapeutics Inc Notable Labs Ltd
Headquarters United States of America United States of America United States of America United States of America United States of America
City San Jose Somerset New Haven Boston Foster City
State/Province California New Jersey Connecticut Massachusetts California
No. of Employees 4 2,900 246 137 16
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Amit Kumar, PhD Chief Executive Officer; Chairman Executive Board 2017 61
Michael J Catelani Chief Operating Officer; President; Chief Financial Officer Senior Management 2016 59
Pamela D. Garzone, PhD Chief Development Officer Senior Management - -
Lewis H. Titterton, Jr. Director Non Executive Board 2017 81
Arnold Baskies, MD Director Non Executive Board 2018 76
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Anixa Biosciences Inc key executives to enhance your sales strategy Gain insight into Anixa Biosciences Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?